Efficacy and Safety of Apatinib Plus Vinorelbine in Patients With Wild-Type Advanced Non–Small Cell Lung Cancer After Second-Line Treatment Failure: A Nonrandomized Clinical Trial

IMPORTANCE: There is currently no standard treatment strategy for patients with advanced non–small cell lung cancer (NSCLC) without driver gene variation after failure of 2 or more lines of chemotherapy. OBJECTIVE: To assess the efficacy and safety of apatinib combined with oral vinorelbine. DESIGN,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xiangyu, Xiong, Yi, Xia, Qing, Wu, Fang, Liu, Lingli, Zhou, Yuling, Zeng, Liang, Zhou, Chunhua, Xia, Chen, Jiang, Wenjuan, Liao, Dehua, Xiao, Lili, Liu, Li, Yang, Haiyan, Guan, Rui, Li, Kunyan, Wang, Jing, Lei, Guang, Zhang, Yongchang, Yang, Nong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082721/
https://www.ncbi.nlm.nih.gov/pubmed/32191330
http://dx.doi.org/10.1001/jamanetworkopen.2020.1226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7082721/
https://www.ncbi.nlm.nih.gov/pubmed/32191330
http://dx.doi.org/10.1001/jamanetworkopen.2020.1226

Ejemplares similares